Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 21:00:08 Europe / Stockholm

Svenska | English

Investor Relations

Public Relations

Redeye

Bifogade filer

Lipum Q2 - Progress on all fronts

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Lipum Q2 - Progress on all fronts

2024-08-09 13:35:00

Redeye provides a research update following the Q2 report published by Lipum earlier today. While the report itself did not include any major surprises, we primarily focus on the recent clinical progress of the company. Following the rights issue and an increased cash position during the spring, Lipum reported positive interim results from the ongoing phase I study. We reiterate our valuation of Lipum with a base case of SEK15.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/